Finasteride Use and Risk of Male Breast Cancer: A Case-Control Study Using Individual-Level Registry Data from Denmark, Finland, and Sweden

    March 2019 in “ Cancer Epidemiology, Biomarkers & Prevention ”
    Thora Majlund Kjærulff, Annette Kjær Ersbøll, A. Green, Martha Emneus, Klaus Brasso, Peter Iversen, Eero Pukkala, Kristian Bolin, Lau Caspar Thygesen
    Image of study
    TLDR Finasteride use is not clearly linked to an increased risk of male breast cancer.
    In 2019, a large-scale study was conducted in Denmark, Finland, and Sweden involving 1,005 male breast cancer cases and 43,058 controls to investigate the potential link between finasteride use and male breast cancer. The results showed no statistically significant increase in the odds of finasteride exposure in breast cancer cases compared to controls. Even after accounting for potential confounders, the odds ratio for the association between finasteride use and male breast cancer decreased. The study concluded that there was no clear relationship between finasteride use and male breast cancer. Despite the large sample size, only 38 cases were exposed to finasteride, indicating that the drug, commonly used to treat hair loss and benign prostatic hyperplasia, was not materially associated with male breast cancer risk.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 1000+ results

      community Male pattern baldness, and mental health

      in Finasteride/Dutasteride  325 upvotes 11 months ago
      A 48-year-old man has been using minoxidil for 15 years and considered finasteride but stopped due to potential side effects. He is concerned about his mental health and the impact of hair loss on self-image, and he encourages support among men experiencing hair loss.

    Similar Research

    6 / 1000+ results
      Male Alopecia, Finasteride, and Cancer Risk

      research Male Alopecia, Finasteride, and Cancer Risk

      February 2012 in “Community oncology”
      Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.
      Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      research Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      November 2020 in “Elsevier eBooks”
      Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.